{"title":"From voluntary efforts to established procedures: the communication our patients need.","authors":"Vicente Javier Baixauli Fernández","doi":"10.33620/FC.2173-9218.2026.28","DOIUrl":"10.33620/FC.2173-9218.2026.28","url":null,"abstract":"<p><p>Coordination between primary care physicians and community pharmacists remains an unresolved issue within the Spanish National Health System. This editorial reviews the evolution of the proposals promoted by SEMERGEN and SEFAC to establish bidirectional communication channels between these two professional groups. It also examines initiatives developed in different autonomous communities and argues for the need to transform a longstanding demand into an integrated care procedure. Improving this communication would represent progress in continuity of care, patient safety, and healthcare system efficiency.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e254"},"PeriodicalIF":0.7,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13383676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-07-10eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.26
Roberto Lozano, Carina Bona
{"title":"Clinical relevance of cytochrome P450-mediated drug-drug interactions in hospitalised older adults: implications for community pharmacy.","authors":"Roberto Lozano, Carina Bona","doi":"10.33620/FC.2173-9218.2026.26","DOIUrl":"10.33620/FC.2173-9218.2026.26","url":null,"abstract":"<p><p>Cytochrome P450 (CYP)-mediated drug-drug interactions constitute a relevant safety issue in hospitalised older patients, due to multimorbidity and polypharmacy. The objective was to characterise these interactions and analyse the factors associated with their occurrence. A retrospective observational study was conducted in a cohort of patients aged ≥ 65 years admitted between 2020 and 2023. Data from the electronic prescribing system were analysed using descriptive statistics, bivariate analysis and multivariate logistic regression, evaluating the association between clinically relevant interactions and clinical and demographic variables. CYP3A4 was the most frequently involved isoenzyme, followed by CYP2C19 and CYP2D6. Although the total number of interactions was high, only a proportion was considered clinically relevant. In the multivariate analysis, polypharmacy was independently associated with the presence of interactions, whereas age, sex, Charlson index and admission diagnosis showed no significant association. These results highlight the need for pharmacist-led medication reconciliation and coordinated deprescribing strategies between hospital and community pharmacy, emphasising the role of the latter in detecting clinically relevant interactions, especially during care transitions after hospital discharge.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e256"},"PeriodicalIF":0.7,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13356572/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-07-10eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.27
Andrea Rodríguez Esquíroz, Patricia García González, Arantza Viamonte Ezcurdia, Marta Marín Marín, Amaya Echeverría Gorriti, Ana Otamendi Murillo, Marta Galipienzo Jimenez
{"title":"Improving patient care: communication channel between health centres and community pharmacies through the electronic prescribing application.","authors":"Andrea Rodríguez Esquíroz, Patricia García González, Arantza Viamonte Ezcurdia, Marta Marín Marín, Amaya Echeverría Gorriti, Ana Otamendi Murillo, Marta Galipienzo Jimenez","doi":"10.33620/FC.2173-9218.2026.27","DOIUrl":"10.33620/FC.2173-9218.2026.27","url":null,"abstract":"<p><p><b>Introduction:</b>Navarra´s healthcare model is based on coordination between healthcare levels and the integration of diverse healthcare professionals across them. The objectives of this study were describe the design, implementation, and evaluation a communication channel between Primary Care (PC) teams and Community Pharmacies (CP) within each Basic Health Zone in Navarra, integrated into the electronic prescription system. <b>Materials and Methods:</b> A channel was designed to enable interaction between CP and PC professionals through the electronic prescription. A procedure was developed, outlining responsibilities, notification protocols and the distinction between urgent and non-urgent incidents. For the evaluation, a satisfaction survey was distributed to all participants. <b>Results:</b> The system was progressively expanded since 2021, reaching 95% of PC teams and 100% of CPs in 2024. Satisfaction surveys revealed a high appraisal of the channel, particularly among CPs, highlighting its utility, improvements in work organization and optimization of resolution times. <b>Conclusion:</b> The implementation of an appropriate communication channel between PC teams and CPs is essential for enhancing patient care. This channel has improved the quality of interprofessional collaboration, acting as a catalyst for alignment and trust between HC and CP professionals.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e266"},"PeriodicalIF":0.7,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13356573/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148550715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-25eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.25
C Díaz López
{"title":"Debunking Constipation Myths: What Community Pharmacists Need to Know.","authors":"C Díaz López","doi":"10.33620/FC.2173-9218.2026.25","DOIUrl":"10.33620/FC.2173-9218.2026.25","url":null,"abstract":"<p><p>Constipation is a highly prevalent gastrointestinal disorder that significantly impacts quality of life and is associated with a substantial healthcare burden. Despite advances in its clinical understanding, its management remains hindered by the persistence of myths and unfounded beliefs that compromise appropriate treatment and obstruct effective healthcare intervention. This study aims to identify, analyze, and clarify some of the most frequent misconceptions surrounding constipation, providing community pharmacists with an evidence-based tool to enhance their clinical and educational practice. A narrative review of the scientific literature published between 2015 and 2025 was conducted, drawing from biomedical databases (PubMed, ScienceDirect, Cochrane) and institutional sources. Selected materials included articles, clinical guidelines, and consensus documents focused on myths related to the pathophysiology, treatment, and prevention of constipation. Among the most prevalent misconceptions are: the necessity of daily bowel movements, the effectiveness of increased fluid intake or olive oil on an empty stomach, the alleged harmfulness or addictive potential of laxatives, the belief that affects only women, and its supposed direct link to colorectal cancer. Misunderstandings regarding the role of dietary fiber, probiotics, and specific foods were also explored. The findings reveal a significant discrepancy between popular beliefs and current scientific knowledge. It is concluded that community pharmacists, as first-line healthcare providers, must play an active role in dispelling misconceptions about constipation through rigorous, evidence-based, and personalized patient education.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e209"},"PeriodicalIF":0.7,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13310362/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148362929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-17eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.24
A Vera Peña, S Dévora Gutiérrez, C Morales Marrero, I Vitória Figueiredo, R Sicilia González, S Abdala Kuri
{"title":"Pharmacotherapeutic Optimization in a Polymedicated Patient Through Coordinated Pharmaceutical Intervention: A Community Pharmacy Case Report.","authors":"A Vera Peña, S Dévora Gutiérrez, C Morales Marrero, I Vitória Figueiredo, R Sicilia González, S Abdala Kuri","doi":"10.33620/FC.2173-9218.2026.24","DOIUrl":"10.33620/FC.2173-9218.2026.24","url":null,"abstract":"<p><p><b>Case presentation:</b> An 82-year-old woman, polymedicated (receiving chronic treatment with ten active pharmaceutical ingredients) and independent for basic activities of daily living, was evaluated. Following a hospital consultation due to fatigue and electrolyte disturbances, a family member attended the community pharmacy (CP) with the clinical documentation, requesting support to improve adherence and pharmacotherapy follow-up through repackaging using a Multicompartment Compliance Aid (MCA) [1]. <b>Case study and evaluation:</b> During the initial interview, several Drug-Related Problems (DRPs) were identified: inappropriate dosage of olmesartan/hydrochlorothiazide, combination of diuretics with kaliuretic effect (torasemide and hydrochlorothiazide), prolonged use of omeprazole without current indication, lack of recent laboratory monitoring in the management of hypercholesterolemia, untreated cognitive impairment, and unnecessary prescription of paracetamol. These DRPs posed a risk of generating Negative Outcomes associated with Medication (NOMs) within the three categories established by the Community Pharmacy Pharmaceutical Care Forum: necessity, effectiveness, and safety (2). <b>Intervention:</b> From the community pharmacy, and in coordination with the family and the primary care team, the dosage regimen of olmesartan/hydrochlorothiazide was adjusted, torasemide and paracetamol were discontinued, the atorvastatin dose was modified according to recent laboratory results, and, following specialist recommendation, memantine 10 mg/day together with cognitive stimulation measures was initiated. <b>Results:</b> Serum potassium levels normalized, adequate blood pressure control was achieved, the lipid profile was optimized, and therapeutic adherence improved through the use of the MCA. The patient reported better sleep quality, absence of pain, and greater functional autonomy. <b>Conclusions:</b> Coordinated intervention between community pharmacy, family environment, and primary care allowed optimization of pharmacotherapy, reduction of overmedication, and improvement in quality of life. This case illustrates the clinical and social value of Professional Pharmaceutical Care Services when developed within an integrated care framework, reinforcing the strategic role of community pharmacy in the comprehensive care of older polymedicated patients within a person-centered healthcare model.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e253"},"PeriodicalIF":0.7,"publicationDate":"2026-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13274723/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148362980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-06-03eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.23
S Nadal Domingo, S Mir Palomo, D Domingo Tortajada
{"title":"Management of Nocturnal Hypoglycaemia in a Patient with Type 2 Diabetes: The Role of Community Pharmacy.","authors":"S Nadal Domingo, S Mir Palomo, D Domingo Tortajada","doi":"10.33620/FC.2173-9218.2026.23","DOIUrl":"10.33620/FC.2173-9218.2026.23","url":null,"abstract":"<p><p>62-year-old woman with type 2 diabetes mellitus (T2DM) and chronic kidney disease presented to the community pharmacy due to episodes of nocturnal hypoglycemia. Interventions were carried out including diabetes education, adjustment of the insulin regimen, and personalized dietary recommendations, which eliminated the hypoglycemic episodes, improved glycemic control, and enhanced the patient's quality of life. This case highlights the key role of community pharmacy in detecting and resolving medication-related problems in chronic patients.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e234"},"PeriodicalIF":0.7,"publicationDate":"2026-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13231406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148266569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-05-21eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.22
R O Pérez Rodríguez, M González Valdivieso, M A Blázquez Ferrer
{"title":"Comprehensive management of a chronic patient in community pharmacy: impact of Comprehensive Medication Management on health outcomes and quality of life.","authors":"R O Pérez Rodríguez, M González Valdivieso, M A Blázquez Ferrer","doi":"10.33620/FC.2173-9218.2026.22","DOIUrl":"10.33620/FC.2173-9218.2026.22","url":null,"abstract":"<p><p>A 56-year-old male with asthma, ischemic heart disease, and hyperuricemia attended the San Francisco Javier Pharmacy with knee and ankle swelling problem. Through the implementation of Comprehensive Medication Management (CMM), a patient-centered intervention was developed that included in-depth interviews, pharmacotherapy review, and collaboration with primary care. Eight drug-related problems (DRPs) were identified, six of which were resolved, highlighting the disappearance of joint symptoms that were highly limiting to daily life. Clinical and functional improvements were observed, along with a significant enhancement in health-related quality of life indicators assessed using the EQ-5D-5L questionnaire. The patient reported an increase in EQ-VAS from 10 to 90 and a gain in quality-adjusted life years (QALYs). This case highlights the effectiveness of CMM in optimizing therapeutic outcomes and improving quality of life in complex patients with polypharmacy. It also reinforces the value of community pharmacies as accessible health agents capable of delivering integrated, biopsychosocial care.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e239"},"PeriodicalIF":0.7,"publicationDate":"2026-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13231407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148266607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-05-20eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.(2026).21
N F Andrés-Rodríguez, I Busto-Domínguez, R Mera-Gallego, I Mera-Gallego, B Guisado Barral, L León Rodríguez, M González Blanco, J A Fornos-Pérez
{"title":"Burnout in Galician Community Pharmacists.","authors":"N F Andrés-Rodríguez, I Busto-Domínguez, R Mera-Gallego, I Mera-Gallego, B Guisado Barral, L León Rodríguez, M González Blanco, J A Fornos-Pérez","doi":"10.33620/FC.2173-9218.(2026).21","DOIUrl":"10.33620/FC.2173-9218.(2026).21","url":null,"abstract":"<p><p><b>Justification</b> There is a lack of studies on the physical wear and mental exhaustion experienced by community pharmacists (CPs) in the workplace, so we consider it necessary to assess its relevance. <b>Objective</b> To analyze the prevalence and significance of occupational burnout syndrome in community pharmacies in Galicia, its risk factors, and its association with work-related and demographic variables. <b>Methods</b> <i>Design:</i> Cross-sectional observational study conducted from September to December 2025. Approved by the Galicia Research Ethics Committee (CEIC Galicia). <i>Subjects:</i> Pharmacists practicing in community pharmacies. <i>Sample size:</i> For a precision of 10.0% in estimating a proportion, assuming a prevalence of 50.0% and a total population size of 3,984, it will be necessary to include 94 participants in the study. <i>Variables:</i> Proportion of CPs affected by burnout syndrome and mean level of affectation according to the total score of the Maslach Burnout Inventory (MBI-HSS). Scores for the sections on considerations and expectations regarding professional practice: frequency (%). <i>Procedure:</i> An online questionnaire was created using Microsoft Forms®. The sample was stratified by province and place of practice according to the classification established by the Xunta de Galicia into three population zone types: densely populated, intermediate, and sparsely populated. Pharmacies will be contacted by phone to offer one pharmacist the opportunity to participate in the study. If they agree, a link to the form and instructions will be sent to their email. <b>Applicability</b> The aim is to establish a starting point to raise awareness and facilitate the approach to burnout syndrome among CPs. This will make it possible to develop prevention and coping strategies.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e259"},"PeriodicalIF":0.7,"publicationDate":"2026-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13215453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148057522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Farmaceuticos ComunitariosPub Date : 2026-05-13eCollection Date: 2026-07-15DOI: 10.33620/FC.2173-9218.2026.20
L Parra-Astorgano, R Prats Mas, I Villegas Lama, I Busto Domínguez, C Morales Marrero, M Roig Marín-Yaseli, J López Gil
{"title":"Design of a Pharmaceutical Protocol for the Evaluation of Phytotherapeutic Products.","authors":"L Parra-Astorgano, R Prats Mas, I Villegas Lama, I Busto Domínguez, C Morales Marrero, M Roig Marín-Yaseli, J López Gil","doi":"10.33620/FC.2173-9218.2026.20","DOIUrl":"10.33620/FC.2173-9218.2026.20","url":null,"abstract":"<p><strong>Introduction: </strong>The growing use of phytotherapy and the increasing heterogeneity of available formulations require community pharmacists to critically assess marketed products based on criteria of quality, safety, and efficacy.</p><p><strong>Objectives: </strong>To design an operational protocol to support community pharmacists in the evaluation and decision-making process regarding plant-based products.</p><p><strong>Methods: </strong>A consensus process was conducted by the SEFAC Fitoterapia Commission, involving the development and integration of structured checklists and the selection of open-access data sources. A decision tree was defined, starting from the legal classification, and an analytical framework for product evaluation was established. Finally, a rapid reporting template was designed for use in community pharmacy practice.</p><p><strong>Results: </strong>The resulting protocol provides a structured approach to the evaluation of phytotherapeutic products, organized into five sections and a rapid report. It is based on a sequential assessment of legal classification, scientific evidence, quality, safety, and patient information. Its implementation is supported by official, reliable, and openly accessible databases available to community pharmacists.</p><p><strong>Conclusions: </strong>The proposed protocol facilitates consistent and traceable pharmaceutical decision-making by integrating regulatory and scientific information into a practical and applicable tool for community pharmacy.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 3","pages":"e252"},"PeriodicalIF":0.7,"publicationDate":"2026-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13169827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147943214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[12th SEFAC Congress: From Transformation to Action in Community Pharmacy].","authors":"V J Díaz Jiménez, E Pérez Hoyos","doi":"10.33620/FC.2173-9218.2026.09","DOIUrl":"10.33620/FC.2173-9218.2026.09","url":null,"abstract":"<p><p>Community pharmacy is undergoing a process of transformation driven by technological innovation, the evolution of healthcare models, and the growing demand for therapeutic personalization. In this context, the Congress of the Spanish Society of Clinical, Family and Community Pharmacy serves as a forum to analyse these changes from a scientific and professional perspective..</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"18 2","pages":"e227"},"PeriodicalIF":0.7,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13080277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147699865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}